Abstract Body

Background: Coinfection with M. tuberculosis (Mtb) and other Mycobacteria is a leading cause of morbidity and mortality in HIV+ patients. While neither monocytes nor NK cells are directly infected with HIV, several of their phenotypic and functional properties become altered during chronic infection, and both cell types are important to the control of Mtb. We hypothesized that HIV-related NK cell dysfunction may result from impaired monocyte dysfunction and impaired crosstalk with NK cells, which we will evaluate in the context of Mycobacteria infection. Methodology: To assess monocyte cytokine production, whole blood from HIV+ ART-naive patients and healthy donors was stimulated with Mycobacteria for 6 hours (in the presence of Brefeldin-A) and followed by intracellular cytokine staining. For cellular functional assays, cells were isolated from PBMC via maganetic bead isolations. Monocytes were infected with fluorescent (mCherry) BCG (opportunistic pathogen) or Mtb at MOI10 for 6 hours to assess phagocytosis. Autologous NK cells were utilized to assess cell killing. Results: We observed a decrease in IL-12 (p=0.017), but similar TNF-alpha production, by blood monocytes from HIV+ individuals following a 6 hour stimulation with M. Bovis BCG (opportunistic pathogen), compared to uninfected donors. As IL-12 is known to regulate NK cell functionality, we were also interested in evaluating NK cell function in our cohort. While developing a flow-based functional assay to measure NK cell killing of autologous Mtb-infected monocytes, we found that NK cells from HIV+ donors exhibited decreased killing of target K562 cells compared to controls (p=0.04). Further evaluation established that monocytes from the same HIV+ patients in which we identified lower NK cell killing also exhibited decreased phagocytosis of fluorescentlylabeled BCG (p=0.016) but similar phagocytosis of Mtb compared to uninfected donors. Conclusions: Our data demonstrate a reduction in both monocyte and NK cell functionality in the same HIV-infected patients and is suggestive of synergism in the dysfunction of two innate cell types in our patients. The assays described have the potential to identify novel therapeutic targets to enhance innate (both monocyte and NK cell) cellular function in HIV-infected patients.